The use of pan-cancer analysis of ADAMTS9 expression in various cancer types

Epigenomics. 2021 Feb;13(4):253-256. doi: 10.2217/epi-2020-0406. Epub 2021 Jan 27.

Authors

Shijun Jiang^{1

2}, Ying Jiang¹, Yingli Cao³, Yiyang Zhao⁴, Hongfeng Liu¹, Xiuli Wang¹, Zikang He¹, Zheyao Song¹, Xingyun Wang¹, Gang Liu¹, Rongjun Cui¹

Affiliations

¹ Department of Biochemistry & Molecular Biology, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, PR China.
² Department of Clinical Laboratory, Daqing Medical College, Daqing, Heilongjiang 163311, PR China.
³ Department of pathology, Heilongjiang Nursing College, Harbin, Heilongjiang 150000, PR China.
⁴ The 1st Clinical Medical College, Southern Medical University, Guangzhou, Guangdong 510000, PR China.

PMID: 33502246
DOI: 10.2217/epi-2020-0406

No abstract available

Keywords: ADAMTS9; angiogenesis; cancer; expression; extracellular matrix; promoter hypermethylation.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

ADAMTS9 Protein / genetics*
Carcinogenesis / genetics
Genome / genetics
Humans
Neoplasms / genetics*

Substances

ADAMTS9 Protein
ADAMTS9 protein, human